- SPACs
- Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp.
Definitive agreement 2026-10-12- CIK 1946021
- HSPO
- IPO 2022-12-22
- $754K trust
- 158 filings
- IPO Size
- $69M
- raised at the IPO
- Trust
- $754K
- as of 2026-06-30
- Current Status
- Definitive Agreement
- from its latest filing
- IPO Year
- 2022
- year it listed
Filings, by quarter
158 filings over 18 quarters; violet bars carry a milestone
- 22 Q3: 1 filing
- 22 Q4: 18 filings
- 23 Q1: 5 filings
- 23 Q2: 1 filing
- 23 Q3: 4 filings
- 23 Q4: 9 filings
- 24 Q1: 11 filings
- 24 Q2: 8 filings
- 24 Q3: 12 filings
- 24 Q4: 24 filings
- 25 Q1: 18 filings
- 25 Q2: 13 filings
- 25 Q3: 8 filings
- 25 Q4: 9 filings
- 26 Q1: 7 filings
- 26 Q2: 6 filings
- 26 Q3: 2 filings
- 26 Q4: 2 filings
- S-1 filed 22 Q3
- IPO 22 Q4
- Definitive agreement 26 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2022-09-27 Filed S1
- IPO2022-12-22 IPO, search begins
- Definitive Agreement2026-10-12 Agreement for merger
- CompletedNot yet completed
About
Horizon Space Acquisition I Corp. is a blank-check company formed to complete a business combination with one or more businesses.
Key Information
As the filings state it
- IPO Date
- 2022-12-22
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- Merger Target
- ArcheNova Biotech Corp.
- SPAC Ticker
- HSPO
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Mingyu (Michael) Li brings private equity, M&A, capital management and public-company experience. Independent director nominees Angel Colon, Mark Singh and Rodolfo Jose Gonzalez Caceres bring experience in financial and investment services, marketing and client relations, and energy-sector consulting and external relations.